Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

563
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
563
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

580
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
580

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population-based anti-Müllerian hormone reference intervals help define gonadal status in the bitch.

Journal of the American Veterinary Medical Association·2024
Same author

An investigation of the discrepancy between set and actual temperature of neonatal incubators: concern for hypothermia and hyperthermia.

Journal of the American Veterinary Medical Association·2023
Same author

Canine Semen Evaluation and Processing.

The Veterinary clinics of North America. Small animal practice·2023
Same author

Progesterone Analysis in Canine Breeding Management.

The Veterinary clinics of North America. Small animal practice·2023
Same author

Randomized Comparative Trial of Acupuncture and Exercise Versus Uterine Ecbolics in the Treatment of Persistent Postbreeding Endometritis in Mares.

Journal of equine veterinary science·2020
Same author

Helping Miracles Happen.

The Veterinary clinics of North America. Small animal practice·2018

Related Experiment Video

Updated: Feb 8, 2026

Author Spotlight: Development and Application of a Canine IBD Gut-on-a-Chip Model for 3D Intestinal Morphogenesis Studies
07:10

Author Spotlight: Development and Application of a Canine IBD Gut-on-a-Chip Model for 3D Intestinal Morphogenesis Studies

Published on: February 9, 2024

3.7K

Canine Prostate Disease.

Bruce W Christensen1

  • 1Kokopelli Assisted Reproductive Services, Franklin Ranch Pet Hospital, 10207 Franklin Boulevard, Elk Grove, CA 95757, USA.

The Veterinary Clinics of North America. Small Animal Practice
|June 24, 2018
PubMed
Summary

Benign prostatic hyperplasia is common in intact male dogs over 6 years old. Neutered dogs face higher prostate cancer risks, while new diagnostics and updated treatments, like shorter antibiotic courses, are now available.

Keywords:
Benign prostatic hyperplasia (BPH)Canine prostate-specific arginine esterase (CPSE)ProstateProstatic neoplasiaProstatitis

More Related Videos

Derivation and Differentiation of Canine Ovarian Mesenchymal Stem Cells
11:41

Derivation and Differentiation of Canine Ovarian Mesenchymal Stem Cells

Published on: December 16, 2018

6.1K
Canine Intestinal Organoids in a Dual-Chamber Permeable Support System
11:11

Canine Intestinal Organoids in a Dual-Chamber Permeable Support System

Published on: March 2, 2022

4.3K

Related Experiment Videos

Last Updated: Feb 8, 2026

Author Spotlight: Development and Application of a Canine IBD Gut-on-a-Chip Model for 3D Intestinal Morphogenesis Studies
07:10

Author Spotlight: Development and Application of a Canine IBD Gut-on-a-Chip Model for 3D Intestinal Morphogenesis Studies

Published on: February 9, 2024

3.7K
Derivation and Differentiation of Canine Ovarian Mesenchymal Stem Cells
11:41

Derivation and Differentiation of Canine Ovarian Mesenchymal Stem Cells

Published on: December 16, 2018

6.1K
Canine Intestinal Organoids in a Dual-Chamber Permeable Support System
11:11

Canine Intestinal Organoids in a Dual-Chamber Permeable Support System

Published on: March 2, 2022

4.3K

Area of Science:

  • Veterinary Medicine
  • Canine Urology

Background:

  • Intact male dogs commonly develop benign prostatic hyperplasia and hypertrophy around age 6.
  • While predisposed to infections, only a few dogs show clinical signs.
  • Neutered male dogs exhibit a higher incidence of prostate neoplasia.

Purpose of the Study:

  • To discuss updated diagnostic tests for canine prostate conditions.
  • To compare castration with medical treatment options.
  • To provide updated treatment recommendations for canine prostatic diseases.

Main Methods:

  • Review of updated diagnostic tests, including canine prostate-specific arginine esterase.
  • Comparison of castration versus medical management strategies.
  • Analysis of current treatment guidelines for prostatic infections and neoplasia.

Main Results:

  • New diagnostic tools enhance the identification of prostate conditions.
  • Treatment strategies are evolving, with specific recommendations for bacterial infections and neoplastic disease.
  • Reduced antibiotic exposure (4 weeks) is recommended for bacterial prostatitis.

Conclusions:

  • Early diagnosis and tailored treatment are crucial for canine prostatic health.
  • Updated management strategies aim to improve outcomes and reduce complications.
  • Focus on targeted therapies for specific prostatic conditions in dogs.